Qualify For Virotherapy in New Zealand From Home and Get The Answer In 48-72 Hours
We receive a lot of inquiries from New Zealanders about the effectiveness of virotherapy, its side effects, whether Rigvir® can be combined with other therapies and how much the treatment costs.
A few words about Rigvir®. The drug was registered in Latvia in 2004, followed by Georgia in 2015 and Armenia in 2016. Recently Rigvir® manufacturer has received the EU funding program grant ‘Horizon 2020’ to make the drug accessible throughout Europe. The registration by local authorities in New Zealand and neighbouring Australia may be the long-term goal.
The Cancer Society of New Zealand website shows no results if you enter ‘Rigvir®’ or ‘virotherapy’. But you can still qualify for the treatment at the world’s only virotherapy center of excellence located in Latvia and continue your virotherapy treatment in New Zealand. So let’s see what’s needed to learn if you or someone you know can benefit from Rigvir®.
Before we proceed to the list of required medical files you should submit to get your free case assessment, please consider the following requirements to qualify for Rigvir®:
- You must be 18 y.o. or older because the clinical trials with Rigvir® were carried out on adults. So far, there has been no proof the drug can help treat pediatric cancer.
- Your malignancy must be solid because Rigvir® can’t help treat blood cancers such as multiple myeloma, leukemia, and lymphoma.
- You must possess a confirmed oncological diagnosis because Rigvir® can only be applied in cancer cases and by no means as a preventive measure.
Below in the left column you can find a list of cancer types vulnerable to Rigvir® while the right column lists five medical documents you should submit for further review by the team of oncologists in Latvia.
Within three business days after you submit your files, the doctors will notify you whether you can be a candidate for virotherapy, how much it will cost, and what to do next.
A Week-Long Inpatient Care In Latvia PLUS a Three-Month Virotherapy Treatment in New Zealand for 11,750 NZD
If you get admitted to the virotherapy course, the oncologists in Latvia may recommend a 7-day Complex Virotherapy Start-Up Package in Latvia including a home-based follow-up care that lasts three months. This is because your inpatient stay allows them to track your condition on daily basis and adjust the Rigvir® dosage accordingly.
When landing in Riga International Airport, you don’t have to think about the transfer. The English-speaking driver will meet you with a welcome sign with your name on it and will drive you to the clinic. Normally the drive takes up to half an hour. Together with daily care, blood tests and 3 Rigvir® injections it encompasses psychological help and ongoing medical support within the period of 3 months. The price for the package is 7,000 Euros (11,750 NZD).
Talking about travel costs, the cheapest one-way ticket starts with 1,092 NZD with flight duration of 44 hours if booked 1 month is advance. This flight implies flying from Wellington to Sydney, from Sydney to Dubai, from Dubai to London, and from London to Riga. However, if you want to spend only 31 hours in the air, choose the flight offered by Air New Zealand, China Airlines, Etihad Airways and airBaltic with the price 1,975 NZD.
Three-Month Outpatient Virotherapy Treatment in New Zealand for 5,205 NZD
The team of oncologists in Latvia offer Remote Virotherapy Start-Up Package on a very rare occasion only if a patient is too weak to travel abroad. The major requirement is that your oncologist in New Zealand will have to discuss your health condition with the one in Latvia to agree on the treatment method from which you’ll benefit most.
Chances are, you still have a lot of questions about the virotherapy treatment in New Zealand, i. e. how to qualify? will Rigvir® help fight your diagnosis? Please click the button below and we'll get back to you within the first 24 hours with the detailed answers.